SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 16, 2026

CTSO

Cytosorbents Corp
BULLISH
Impact 6/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $48K total
Actionable Insight ▲ Bullish

The insider buying cluster suggests management sees value at current levels (~$0.40-$0.44). Traders should monitor for upcoming catalysts (earnings, product news) that could validate this confidence. Given the micro-cap nature and low liquidity, position sizing should account for volatility.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CTSO ▼ -38.23% at T+60d
LONG call ✗ call lost -38.23% · α vs SPY -40.10% · entry $0.5189 → $0.3205
Entry = T+0 close
Jun 16, 2026
via day close
T+1d
-8.07%
call -8.07% · α -6.83%
$0.4770
settled 4mo ago
T+5d
-10.00%
call -10.00% · α -7.72%
$0.4670
settled 4mo ago
T+20d
-28.81%
call -28.81% · α -28.86%
$0.3694
settled 3mo ago
T+60d
-38.23%
call -38.23% · α -40.10%
$0.3205
settled 7w ago

Price Chart

Loading chart...

Executive Summary

CEO Phillip Chan and CFO Peter Mariani of Cytosorbents (CTSO) collectively purchased ~$149K of stock in open-market transactions over three days, representing ~0.55% of market cap. This is a strong insider buying cluster at a micro-cap with bearish analyst consensus, signaling management's conviction in the company's prospects.

Key Financial Metrics

Direction
buying
Total Value
$148.9K
Insiders
2

Key Facts

  • CEO Phillip Chan purchased 251,136 shares at $0.40 on June 12 and 10,333 shares at $0.43 on June 15, totaling ~$105K.
  • CFO Peter Mariani purchased 100,000 shares at $0.44 on June 15, totaling $44K.
  • Total insider purchases of ~$149K represent 0.55% of CTSO's $27M market cap.
  • Both top executives bought on the open market, not via options or grants.

Financial Impact

$149K in insider purchases, ~0.55% of market cap

insider ownershipmarket sentiment

Risk Factors

  • Micro-cap volatility and low trading volume could amplify price swings.
  • Negative analyst consensus (0% bullish) may weigh on sentiment.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CTSO-1781607656029
6 reports for CTSO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CTSO — sortable, filterable
TypeNow
Sep 23, 2026
4w ago
8-K
MIXED ★ 5/10
$4.91 $5.35▲ +8.96%▲ +8.27%$4.73 (−3.67%)
Aug 6, 2026
11w ago
Press Release
BEARISH ★ 6/10
$0.3600 $0.3501▲ +2.75%▲ +2.35%$4.73 (−1213.89%)
Jun 25, 2026
17w ago
DEFA14A
NEUTRAL ★ 3/10
$0.3620 $0.3600▼ −0.55%▼ −1.94%$4.73 (+1206.63%)
Jun 16, 2026
19w ago
Insider Cluster
BULLISH ★ 6/10
$0.5189 $0.3694▼ −28.81%▼ −28.86%$4.73 (+811.54%)
Apr 15, 2026
27w ago
10-K/A
NEUTRAL ★ 2/10
$0.6100 $0.5710▼ −6.39%▼ −12.21%$4.73 (+675.41%)
Apr 2, 2026
29w ago
8-K
BEARISH ★ 8/10
$0.5830 $0.6100▼ −4.63%▲ +5.25%$4.73 (−711.32%)
Showing 6 of 6

US Market Status

Market Open — Closes in 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 16, 2026